ASCO Expanding Tools To Improve Coordination Of Cancer Treatment
PET Three Months After Therapy Provides Early Warning Of Need For Intervention
Nexavar Approved For Patients With Inoperable Liver Cancer
Erbitux Improves Survival In Advanced Colorectal Cancer
Revlimid Plus Steroid Effective In Clinical Trial
NCI-Approved Clinical Trials Begun At Groups, Centers
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery